中华放射肿瘤学杂志
  Home | Journal | Editorial | Instruction | Subscription | Advertisement | Academic | Index-in | Contact Us | Chinese
中华放射肿瘤学杂志
  Office  
 

Journal

 
   Forthcoming Articles
   Current Issue
   Next Issue
   Advanced Search
   Archive
   Download Articles
   Read Articles
   Email Alert
   RSS
  Download  
   Instruction
   Template
   Copyright Agreement
          More  
 
Quick Search  
  Advanced Search
Chinese Journal of Radiation Oncology
 
2019 Vol.28 Issue.11
Published 2019-11-15

Head and Neck Tumors
Abdominal Tumors
Thoracic Tumors
Physics·Biology·Technique
Special Feature
Review Articles
Invertigation Research
Special Feature
801 Application of deep inspiration breath-hold technique in radiotherapy
Zhong Renming, Bai Sen
In radiotherapy for thoracic and abdominal tumors,the negative effect of respiratory movement on radiotherapy persist throughout the whole process of radiotherapy. Deep inspiration breath-hold technique (DIBH) is a method of respiratory movement management in radiotherapy,which can reduce the negative effect of respiratory movement upon radiotherapy in the whole process of radiotherapy. Meantime,DIBH technique has its own characteristics and operation requirements compared with other respiratory movement management measures (such as 4D CT,gated technology and tracking,etc.). The aim of this review was to introduce the advantages, disadvantages and the application status of DIBH technique.
2019 Vol. 28 (11): 801-805 [Abstract] ( 156 ) [HTML 1KB] [ PDF 0KB] ( 0 )
Invertigation Research
806 Relationship between breast reconstruction surgery and radiotherapy after mastectomy-a cross-sectional survey based on 110 hospitals in China
Zhang Qi, Li Lun, Xiu Bingqiu, Guo Rong, Yang Benlong, Wang Jia, Su Yonghui, Chi Weiru, Zhang Yingying, Cao Ayong, Shao Zhimin, Wu Jiong

Objective To investigate the current status of breast reconstruction surgery in China and analyze the specific views of Chinese doctors on the relationship between radiotherapy and breast reconstruction surgery. Methods A total of 110 medical institutions nationwide with more than 200 cases of breast cancer surgery yearly were selected into this questionnaire survey. The questionnaire survey included basic information of the surgeons and their hospitals, information of breast cancer surgeries in 2017,types of reconstruction surgery and specific views on the relationship between radiotherapy and reconstruction surgery. Results In total, 110 hospitals participated in the survey, 96(87.3%) had undergone breast reconstruction surgery. Reconstruction with implants accounted for 65.7% of the total reconstruction surgery and the proportion of autologous reconstruction was 20.1%. For patients who probably required postoperative radiotherapy, the preferred surgical procedure in the surveyed hospitals was implant based reconstruction surgery. For those who were confirmed to receive postoperative radiotherapy or had undergone radiotherapy after total mastectomy, autologous tissue reconstruction was recommended. Postoperative radiotherapy was a negative factor for immediate breast reconstruction, and most hospitals believed that radiotherapy exerted slight effect on surgery. Theproportion of delay-immediate breast reconstruction reached 66% and 86% of hospitals preferred to replace with the prosthesis at 6 months after radiotherapy. Patients with local recurrence after breast-conserving surgery could also receive immediate reconstruction and implant reconstruction was the preferred surgical procedure. Conclusions The proportion of breast reconstruction in China is relatively low and Chinese doctors still lack of technical mastery. In the face of conflict with radiotherapy, the regime selected by Chinese doctors is not in accordance with those recommended by the guideline and consensus, prompting that more professional training should be delivered for Chinese doctors to further promote the development of breast reconstruction in China.

2019 Vol. 28 (11): 806-810 [Abstract] ( 214 ) [HTML 1KB] [ PDF 0KB] ( 0 )
Head and Neck Tumors
811 Radiation-induced changes in small world network in patients with nasopharyngeal carcinoma:a three-dimensional structure MRI imaging study
Xin Xin, Cheng Chuandong, Li Churong, Li Jie, Wang Pei, Tian Yin, Yin Gang, Lang Jinyi
Objective To investigate the radiotherapy (RT)-induced changes in the brain structural network in patients with nasopharyngeal carcinoma (NPC). Methods Three-dimensional structural magnetic resonance data (3D-T1W) was adopted to investigate the structural network in 103 patients with NPC before and after receiving RT. The structural networks were then reconstructed using 3D-T1W. The radiation-induced changes in topology properties of small world network were analyzed by using graph theoretical analysis. Results Patients showed small world properties before and after RT. Compared with the pre-RT group, the global and local efficiency were lower, the shortest path length was longer and the clustering coefficient was less in the post-RT group. In addition, the hub regions in the post-RT group were significantly different from those in the pre-RT group, mainly located in the left rolandic operculum, right inferior frontal gyrus, right parahippocampal gyrus, right lingual gyrus, bilateral supramarginal gyrus, left superior temporal gyrus and temporal pole of the right middle temporal gyrus. Conclusion It is speculated that RT leads to high efficiency of network topology and information transmission, which provides a novel perspective for exploring the RT-induced brain changes, diagnosis of RT-induced injury and evaluation of RT efficacy.
2019 Vol. 28 (11): 811-816 [Abstract] ( 196 ) [HTML 1KB] [ PDF 0KB] ( 0 )
817 A analysis of the spatial distribution characteristics of brain metastasis and the risk of hippocampus metastasis in patients with EGFR mutant lung cancer
Wu Junlan, Fan Xingwen, Wang Hongbing, Wu Kailiang
Objective To analyze the spatial distribution of brain metastases in EGFR-mutant lung cancer and the risk of hippocampal metastasis. Methods Patients with lung cancer brain metastases diagnosed and treated in the Shanghai Cancer Center Fudan University from 2006 to 2016 were enrolled. The brain metastasis with positive mutation of EGFR gene was screened. The magnetic resonance images of the patients were reviewed and the distribution characteristics of brain metastasis were analyzed. Results A total of 920 lung cancer patients with brain metastases were screened,266 of whom had EGFR gene mutation detection,and 131(49%) were identified as EGFR gene mutations. Excluding 17 patients who did not have a head magnetic resonance examination in our hospital,a total of 114 patients and 738 lesions were enrolled in this study. The proportion of brain metastases distributed in each brain region was 22.8%,19.5%,22.0%,13.4%,3.3%,16.7%,and 2.2% for frontal,temporal,parietal,occipital lobe,insula,cerebellum,and brainstem,respectively. The number of metastases and cases located in the hippocampus,<5mm from the hippocampus,<10mm from the hippocampus,and<15mm from the hippocampus were 6(0.8%),10(1.3%),11(1.4%),and 14(1.8%),5 cases (4.4%),8 cases (7.0%),9 cases (7.9%),and 11 cases (9.6%),respectively. Conclusion EGFR-mutant lung cancer brain metastasis is low risk in the hippocampus and its surrounding 15mm.
2019 Vol. 28 (11): 817-820 [Abstract] ( 161 ) [HTML 1KB] [ PDF 0KB] ( 0 )
Thoracic Tumors
821 Comparison of clinical prognosis of chemo-radiotherapy and surgical treatment for patients with limited stage small cell lung cancer after matching
Chen Mengyuan, Hu Xiao, Qi Xiaofang, Xu Yujin, Dong Baiqiang, Chen Yamei, Chen Ming
Objective To compare the overall survival (OS), progression-free survival (PFS) and brain metastasis free survival (BMFS) between the chemo-radiotherapy and surgical treatment for patients with limited stage small cell lung cancer (LS-SCLC). Methods Clinical data of 69 patients diagnosed with LS-SCLC undergoing surgery in Zhejiang Cancer Hospital between 2000 and 2016 were collected. According to T,N stage, treatment duration, age, gender and whether or not prophylactic cranial irradiation (PCI), 69 patients of 503 LS-SCLC patients who underwent standard radiochemotherapy were assigned into the radiochemotherapy group by using the pair-matched case-control method. Results Among 138 patients, 69 cases were allocated into the surgery group (24 cases of stage Ⅰ, 14 cases of stage Ⅱ and 31 cases of stage Ⅲ) and 69 cases in the radiochemotherapy group (24 cases of stage Ⅰ, 14 cases of stage Ⅱ and 31 cases of stage Ⅲ). The median OS time was 37.1 months (95%CI:24.1-50.2 months) in surgery group and 45.0 months (95%CI:15.8-74.2 months) in the radiochemotherapy group. The 2-and 5-year OS rates were 60% and 45% in the surgery group, and 64% and 45% in the radiochemotherapy group (P=0.846). The median PFS time was 27.1 months (95%CI:0.00-60.3 months) in the surgery group and 36.2 months (95%CI:20.9-51.4 months) in the radiochemotherapy group. The 2-and 5-year PFS rates were 52%,and 38% in the surgery group, and 56% and 40% in the chemo-radiotherapy group (P=0.610). The 2-and 5-year BMFS rates were 81% and 76% in the surgery group, and 84% and 80% in the radiochemotherapy group (P=0.774). The 5-year OS rate (62% vs. 40%,P=0.038) and 5-year PFS rate (80% vs.40%,P=0.048) for patients with stage Ⅰ LS-SCLC in the surgery group were significantly higher than those in the radiochemotherapy group. However, the 5-year BMFS rate in patients with stage Ⅰ LS-SCLC did not significantly differ between two groups (92% vs.95%, P=0.816). The 5-year OS rate (41% vs.51%, P=0.946), 5-year PFS rate (65% vs.42%, P=0.280) and 5-year BMFS rate (75% vs.78%, P=0.720) for stage Ⅱ SCLC did not significantly differ between two groups. As for stage Ⅲ SCLC patients, the OS rate (25% vs.48%, P=0.220), 5-year PFS rate (28% vs.36%, P=0.333) and 5-year BMFS rate (76% vs. 74%, P=0.84) did not significantly differ between two groups. Conclusions Surgical treatment can bring survival benefits to patients with stage Ⅰ LS-SCLC. The survival prognosis of stage Ⅱ patients is equivalent between two groups. Patients with stage Ⅲ LS-SCLC receiving radiochemotherapy obtain better survival trend compared with those undergoing surgery. The conclusion remains to be validated by studies with larger sample size or prospective investigations.
2019 Vol. 28 (11): 821-825 [Abstract] ( 165 ) [HTML 1KB] [ PDF 0KB] ( 0 )
826 Clinical study of salvage strategy for patients with locally recurrent esophageal cancer after definitive radiochemotherapy
Chen Yongshun, Cheng Xinyu, Song Haixia, Ke Shaobo, Cheng Guowei, Shi Wei, Qiu Hu, Gao Yi, Chen Jiamei
Objective To investigate the salvage strategy and efficacy for patients with locally recurrent esophageal squamous cell carcinoma after definitive radiochemotherapy. Methods A total of 126 patients who met the inclusion criteria were enrolled in this study and divided into the salvage surgery, salvage radiochemotherapy and best supportive care. Results Fifty-eight of 126 patients received salvage esophagectomy, 52 underwent salvage radiochemotherapy and the remaining 16 patients received best supportive care. The 1-,3-,5-year overall survival rates of patients receiving salvage therapy were 51%,16% and 4% for the three groups, whereas all patients in the best supportive care group died within 12.0 months (P<0.001). The 1-,3-,5-year survival rates in the salvage surgery and salvage radiochemotherapy groups were 48%, 20% and 7%, and 51%,11% and 3%,respectively (P=0.473). Multivariate analysis by Cox proportional hazard model showed that T staging of recurrent tumors and salvage regimen were the independent prognostic factors in patients with locally recurrent esophageal cancer (both P<0.001). Postoperative infection occurred in 16% of the patients in the salvage surgery group, and the incidence of esophagotracheal fistula and mediastinoesophageal fistula was 10% and 6% in the salvage radiochemotherapy group. Conclusions A survival benefit can be elicited by salvage surgery or salvage radiochemotherapy in patients with locally recurrent esophageal cancer after definitive radiochemotherapy. Nevertheless, extensive attention should be paid to the management of postoperative complications in clinical practice.
2019 Vol. 28 (11): 826-829 [Abstract] ( 161 ) [HTML 1KB] [ PDF 0KB] ( 0 )
Abdominal Tumors
830 Adjuvant trastuzumab reduces locoregional recurrence in women who underwent mastectomy without radiation therapy for HER-2-positive breast cancer:a retrospective analysis with propensity score matching
Jing Hao, Wang Shulian, Tang Yu, Song Yongwen, Fang Hui, Wang Jianyang, Zhang Jianghu, Jin Jing, Liu Yueping, Qi Shunan, Tang Yuan, Li Ning, Chen Bo, Lu Ningning, Li Yexiong
Objective To investigate the locoregional benefit from adjuvant anti-HER-2 target therapy and the possibility of omitting postmastectomy radiation therapy (PMRT) in HER-2 positive breast cancer patients. Methods Clinical data of 1398 patients diagnosed with HER-2+ breast cancer admitted to our hospital who underwent mastectomy without PMRT from 2009 to 2014 were retrospectively analyzed, and 370 of them received adjuvant anti-HER-2 target therapy mainly with trastuzumab. Results Anti-HER-2 target therapy significantly improved the disease-free survival (DFS) and overall survival (OS), whereas reduced the locoregional recurrence (LRR) insignificantly. Multivariate analysis demonstrated that anti-HER-2 target therapy improved the locoregional recurrence-free survival (LRRFS)(P=0.06). After propensity score matching,the 5-year LRR rate was 4.4% vs. 6.4%(P=0.070) for those treated with and without anti-HER-2 target therapy. Subgroup analysis revealed that the locoregional control benefit was only significant in patients with pathological Grade Ⅰ-Ⅱtumors (2.5% vs. 5.9%,P=0.046). For patients with pN1 tumors with and without anti-HER-2 target therapy,the 5-year LRR rate was 8.2% vs. 12.3%(P=0.150). Patients with hormone receptor-positive tumors obtained significant benefit from anti-HER-2 target therapy. The 5-year LRR rate could be less than 5% in patients with favorable risk factors who received anti-HER-2 target therapy. Conclusions Anti-HER-2 target therapy with trastuzumab can improve the LRRFS of patients with HER-2+ breast cancer after mastectomy. Nevertheless, patients with radiotherapy indications have to receive radiotherapy due to relatively high recurrence rate. Newly approved dual HER-2 blockade is a promising approach to further reduce LRR. Subgroup analysis is required to identify the low-risk patients.
2019 Vol. 28 (11): 830-835 [Abstract] ( 180 ) [HTML 1KB] [ PDF 0KB] ( 0 )
836 A meta-analysis of the efficacy of postoperative adjuvant radiotherapy and non-radiotherapy for extrahepatic cholangiocarcinoma and gallbladder carcinoma
Ren Bixin, Liu lei, Yang Yongqiang, Guo Qi, Zhang Liyuan, Tian Ye
Objective To compare the efficacy of postoperative adjuvant radiotherapy and non-radiotherapy in patients with extrahepatic cholangiocarcinoma and gallbladder carcinoma by a meta-analysis. Methods The controlled clinical trials of postoperative adjuvant radiotherapy versus non-radiotherapy of extrahepatic cholangiocarcinoma and gallbladder carcinoma were searched from PubMed, EMbase, Cochrane Library, Wanfang database, CNKI, Chongqing VIP and CBM databases. The obtained data were analyzed using RevMan 5.3 and Stata 14.0 statistical software. The difference between two groups was estimated by calculating the odds ratio (OR) with 95% confidence interval (CI). Results A total of 20 controlled clinical trials involving 1258 extrahepatic cholangiocarcinoma and gallbladder carcinoma patients were included in this meta-analysis. The meta-analysis demonstrated that the 5-year survival rate in the adjuvant radiotherapy group was significantly higher than that in the non-radiotherapy group (OR=1.67, 95%CI:1.29-2.18, P=0.001). The 5-year survival rates in those with lymph node positive disease (OR=7.44, 95%CI:1.24-44.72, P=0.03) and positive margins disease (OR=3.43,95%CI:1.56-7.75,P=0.002) were significantly enhanced by postoperative adjuvant radiotherapy. The local recurrence rate in the adjuvant radiotherapy group was significantly lower than that in the non-radiotherapy group (OR=0.56,95%CI:0.39-0.80,P=0.01), whereas the distant metastasis rate did not significantly differ between two groups (OR=1.22,95%CI:0.86-1.73,P=0.27). The incidence rates of acute toxicity and chronic toxicity of grade ≥3 caused by radiotherapy were 0-11.9% and 0-21.7%,respectively. Conclusion Compared with non-radiotherapy, postoperative adjuvant radiotherapy is a safer and more effective postoperative treatment for extrahepatic cholangiocarcinoma and gallbladder carcinoma.
2019 Vol. 28 (11): 836-839 [Abstract] ( 216 ) [HTML 1KB] [ PDF 0KB] ( 0 )
840 Analysis of the poor prognostic factors affecting 48 cases of cervical stump carcinoma
Mu Yesai, Ayinuer·Seyiti, Gulina·Kuerban

Objective To explore the poor prognostic factors of patients with cervical stump carcinoma, aiming to provide certain reference for the clinical diagnosis and treatment. Methods Clinical data of 48 patients with cervical stump carcinoma admitted to the Affiliated Tumor Hospital of Xinjiang Medical University from January 1, 2005 to December 1, 2016 were retrospectively analyzed. A total of 19 patients (40%) withⅠA-ⅡA stage cervical stump carcinoma were treated with surgery+ adjuvant therapy and 29 patients (60%) in ⅡB-Ⅳ stage received radiotherapy combined with chemotherapy. The median age of onset was 51 years old. Uterine fibroids were the main cause of subtotal hysterectomy. The average time interval from subtotal hysterectomy to definite diagnosis was 10.76 years. Results The 1-,3-,5-year survival rate was 98%,83% and 74%,respectively. Univariate analysis demonstrated the time interval from subtotal hysterectomy (P=0.016), tumor diameter (P=0.016), clinical stage (P=0.036), histological grade (P=0.009),lymph node metastasis (P=0.044), parametrial invasion (P=0.046), myelosuppression (P=0.013) and radical surgery (P=0.019) were the poor prognostic factors of cervical stump carcinoma. Conclusions Poor prognosis of patients with cervical stump carcinoma is correlated with tumor diameter, clinical stage, histological grade, lymph node metastasis, parametrial invasion and myelosuppression. Histological grade is an independent risk factor.

2019 Vol. 28 (11): 840-842 [Abstract] ( 209 ) [HTML 1KB] [ PDF 0KB] ( 0 )
Physics·Biology·Technique
843 The microdamage of "morphologically normal white matter" in patients with nasopharyngeal carcinoma after radiotherapy and its correlation with the irradiation dose
Ren Wenting, Sun Chao, Wu Runye, Cao Ying, Liang Xin, Xu Yingjie, Ma Pan, Han Fei, Lu Ting, Yi Junlin, Dai Jianrong

Objective To explore the correlation between microdamage in white matter and radiotherapy dose at early stage after radiotherapy (RT) in patients with nasopharyngeal carcinoma (NPC). Methods Thirty-three patients who were initially diagnosed with NPC were recruited and received diffusion tensor imaging (DTI) scan and neuro-cognitive scale test within 1 week before RT and the first day after RT. DTI-related characteristic parameters including fractional anisotropy (FA),mean diffusivity (MD),axial diffusivity (λ‖),and radial diffusivity (λ⊥) were calculated based on whole-brain voxel analysis method. Paired t-test was conducted to evaluate statistical significance between pre-RT and post-RT groups. In the subgroup analysis, all the subjects were divided into 3 groups according to the average dose of temporal lobe, and each group was set with an equal dose interval range. The DTI-related parameters of whole brain pre-RT and post-RT in each group were statistically compared. All the statistical results were corrected by FDR with a threshold of P<0.05 and clusters>100. Results FA, MD, λ‖ and λ⊥in the post-RT group significantly differed compared with those in the pre-RT group (P<0.05). The values of FA, MD, λ‖ and λ⊥were 0.455±0.016,(9.893±0.403)×10-4,(13.441±0.412)×10-4 and (8.231±0.429)×10-4, respectively. Subgroup analysis showed that the extent and degree of λ‖ and λ⊥ changes were exacerbated with the increase of the average dose of temporal lobe after RT. Particularly in high-dose group, the average dose range was 25-35Gy and the extent of regions with significant changes was significantly larger than those in the medium-dose (15-25Gy) and low-dose groups (5-15Gy)(P<0.05). Conclusions DTI can be utilized to detect"normal" brain tissue microdamage in NPC patients at early stage after RT. The average radiation dose of temporal lobe may be one of the reasons for the severity of cerebral microdamage. In the future, DTI technique may be useful for guiding exposure dose of organs at risk during RT planning and to evaluate the cohort with a high risk of cerebral microdamage at early stage after RT, thereby protecting normal cerebral tissues to the maximum extent.

2019 Vol. 28 (11): 843-848 [Abstract] ( 182 ) [HTML 1KB] [ PDF 0KB] ( 0 )
849 Dosimetric effect of set-up errors on nasal NK/T cell lymphoma based on dose reconstruction
Wang Zhanyu, Tan Junwen, Long Yusong, He Xiantao, Li Gang, Feng Yongfu, Liang Weixue
Objective To evaluate the dosimetric effects of set-up errors on nasal NK/T cell lymphoma by introducing set-up errors into the radiotherapy planning system for dose reconstruction. Methods Ten patients with nasal NK/T cell lymphoma were recruited. A non-coplanar volumetric modulated arc therapy plan was designed for CT image and clinical target area of each patient. After the completion of the plan, the set-up errors were introduced into the radiotherapy plan by changing the ISO of the treatment, and dose calculation was performed to reconstruct the dose distribution. Results With the increase of system set-up errors, the dose of target was decreased and the order affected by set-up errors in different directions was:left-right direction> head-foot direction> front-rear direction. When the translational set-up errors in each direction were -3mm to 3 mm and the rotating set-up errors were -3° to 3°, the range of dose change in all targets was less than ±3%. When the set-up errors in all directions were ≤ 3mm,the dose of organ at risk was less than or similar to the prescribed dose. When the set-up errors were> 3mm, the doses of lens, spinal cord, parotid gland and optic nerve gradually exceeded the prescribed dose. Only when the rotating set-up errors were ≥ 3°, the dose of lens exceeded the prescribed dose. Special attention should be paid to the influence of the greater set-up errors in the left and right direction on lens, spinal cord and parotid gland, as well as on the spinal cord due to the larger set-up errors in the front and rear direction. After the actual set-up errors were introduced from our department, it exerted slight effect on the irradiation dose of GTV and CTV, which was less than ±2%. In a few cases, the dose of organ at risk potentially exceeded the prescribed dose limit, and special attention should be diverted to overdose of the lens and optic nerve. Conclusions The set-up errors will result in target dose deficiency and overdose of organ at risk in nasal NK/T cell lymphoma, especially upon the set-up errors in the left and right direction. The effect of 3mm and 3° set-up errors on target and organ at risk is limited. Therefore, it is recommended to maintain the single direction set-up errors within 3mm and 3°. The actual set-up errors introduced from our department exert little effect on the target dose, but a small number of organs are at risk of exceeding the prescribed dose limit. It is necessary to increase the evaluation of the extension region of organ at risk.
2019 Vol. 28 (11): 849-853 [Abstract] ( 167 ) [HTML 1KB] [ PDF 0KB] ( 0 )
854 Experimental study of ginsenoside Rg3 in the treatment of acute radiation proctitis in rat models
Hu Tingting, Cai Hongyi
Objective To evaluate the efficacy of ginsenoside Rg3(GRg3) in the treatment of acute radiation proctitis in rat models. Methods On the 7th day after 21.5Gy irradiation, 100 rats were divided into the control group (normal saline, n=20), GRg3 group (gavage of 20 mg/kg, 40 mg/kg and 80 mg/kg GRg3, n=20 for each dose) and Smecta mixture enema group (n=20). After 2 weeks, all rats were anesthetized with chloral hydrate (3 ml/kg) and approximately 5 ml of blood sample was collected from the abdominal aorta prior to sacrifice. The rectal tissues were taken and prepared for detection of Bax and NF-κB contents and HE staining to observe the pathological changes of the rectal tissues. After the blood samples were centrifuged, the supernatants were collected for ELISA to detect the serum levels of IL-2, IL-6, TNF-α and MPO in each group. Results In the GRg3 group, the serum inflammatory cytokines, serum MPO concentration and the concentration of Bax and NF-κB in the intestinal tissues of rats were decreased along with the increasing dose of GRg3. These parameters in the high-dose GRg3 group were significantly lower than those in the saline group (all P<0.05), whereas did not significantly differ from those in the Smecta mixture enema group (all P>0.05), suggesting that GRg3 exerted good therapeutic effect on acute radiation proctitis in rat models. Conclusions GRg3 can significantly reduce the concentration of inflammatory cytokines, Bax and NF-κB in the intestinal tissues of rat models with acute radiation proctitis, which is more efficacious than the normal saline. GRg3 can be used to treat acute radiation proctitis in rat models.
2019 Vol. 28 (11): 854-857 [Abstract] ( 177 ) [HTML 1KB] [ PDF 0KB] ( 0 )
858 LncRNA ANRIL target miR-195 experimental study of radiation sensitivity of HCT116 cells and nude mouse transplant tumors
Chen Xiaoyan, Wu Chenbin, Tian Xin, Gou Xiaoli, Wu Yingqiang, Zhao Kui, Xie Rui
Objective To investigate the effect and mechanism of LncRNA ANRIL on the radiosensitivity of HCT116 cells line and nude mouse transplant tumors. Methods The expression of LncRNA ANRIL in colorectal cancer cells was detected by qPCR. The negative control siRNA,ANRIL siRNA,miR-NC mimic,miR-195 mimic,miR-NC inhibitor and miR-195 inhibitor were transfected into HCT116 cells,and marked as negative control group,silencing ANRIL group,overexpressing miR-NC group,overexpressing miR-195 group,inhibiting miR-NC group and inhibiting miR-195 group, and the HCT116 cells without any treatment were marked as the blank control group. The clone formation assay was used to detect radiosensitivity of colorectal cancer cells,flow cytometry was used to detect apoptosis. The web site,StarBase,was used to predict the downstream miRNAs of ANRIL and dual luciferase reporter gene assay was used to further verify. Subcutaneous tumor transplantation assay was used to detect the effect of ANRIL on the growth of colorectal cancer cells after irradiation. Results After irradiation with 2,4,6 and 8 Gy,the cell survival fraction of silencing ANRIL group was significantly decreased when compared with that of negative control group (P<0.05),and the radiosensitivity ratio was 1.52. The apoptosis rate of the silencing ANRIL+4 Gy group was significantly higher than that of the negative control+4 Gy group ((27.86±2.78)% vs. (12.06±1.46)%,P<0.05). The results of the experiment on nude mouse transplant tumors showed that the tumor volume in the negative control group was lower than that of the silent ANRIL group on days 13, 16, 19, 22 and 25 ((234±66) mm3,(273±63) mm3,(296±72) mm3,(321±85) mm3 and (403±94) mm3 vs. (357±79) mm3,(485±124) mm3,(617±143) mm3,(764±174) mm3 and (985±221) mm3P<0.05). MiR-195 is a target gene of ANRIL,and inhibition of miR-195 can reverse the inhibitory effect of silencing ANRIL on radiosensitivity,apoptosis and xenografts of HCT116 cells. Conclusions LncRNA ANRIL regulates the radiosensitivity of colorectal cancer cells by miR-195,which may provide a new sensitizing target for clinical colorectal cancer radiotherapy.
2019 Vol. 28 (11): 858-861 [Abstract] ( 172 ) [HTML 1KB] [ PDF 0KB] ( 0 )
Review Articles
862 Flash radiotherapy
Wei Zhao, Yuan Tian, Hao Peng
Flash radiotherapy (Flash-RT) is a treatment modality that uses the normal tissue sparing regimen induced by ultra-high dose rate and ultra-fast irradiation. Compared to conventional dose rate radiotherapy,Flash-RT has the potential to provide the isoefficacy for tumors while achieving the remarkable normal tissue protection. Due to this unique feature,Flash-RT is attracting more and more attention from the radiotherapy community. An abundance of groups from both academia and industry are extensively studying the therapeutic ratio and underlying biological mechanisms. Here,we review the prior knowledge about Flash-RT and summarize the results that have been reported from various groups using both in vitro and animal studies with different experimental protocols. We also discuss possible biological mechanisms and the challenging of implementing Flash-RT,as well as its possible options for clinical applications.
2019 Vol. 28 (11): 862-866 [Abstract] ( 237 ) [HTML 1KB] [ PDF 0KB] ( 0 )
867 Progress in adjuvant therapy decision-making after endoscopic resection of early esophageal cancer
Feng Lingling, Men Yu, Hui Zhouguang
Both endoscopic resection and surgery are the common treatment modes for early esophageal cancer. Compared with radical surgery,endoscopic resection has the advantages of less trauma,quicker recovery,lower cost,less complications,the preservation of the normal anatomy,the physiological function of the esophagus,and higher postoperative quality of life. For patients with a high risk of lymph node metastasis, endoscopic resection alone can lead to inadequate treatment,which need adjuvant therapies. Currently, the common adjuvant therapies consist of adjuvant radiochemotherapy and adjuvant radiochemotherapy combined with surgery. How to combine endoscopic resection with adjuvant therapy to bring maximal benefits to patients has become the hot topic in the field of clinical researches. In this article, the current research status,progress and challenges in the combination of endoscopic resection and adjuvant therapy for the treatment of high-risk patients were reviewed.
2019 Vol. 28 (11): 867-871 [Abstract] ( 157 ) [HTML 1KB] [ PDF 0KB] ( 0 )
872 Research progress on application of the combination of radiotherapy and immune-checkpoint blockade in treatment of stage Ⅲ unresectable non-small cell lung cancer
Li Rutian, Zhu Zhengfei, Wang Lifeng, Yan Jing, Yan Yingtzu, Liu Baorui
Chemoradiation has been the standard treatment of stage Ⅲ unresectable non-small cell lung cancer (NSCLC) for a long period of time. However,the clinical efficacy of chemoradiation has not been significantly improved in recent two decades. In the past 2-3 years,the role of immune-checkpoint inhibitors in metastatic NSCLC has been persistently strengthened. Moreover,the synergistic effect between radiotherapy and immune-checkpoint blockade has been conformed in pre-clinical and clinical studies. Recent clinical trials have demonstrated that the combination of radiotherapy and immune-checkpoint blockade has been proven to be more effective in the treatment of stage Ⅲ unresectable NSCLC. In this article, the latest clinical studies since 2017 regarding the application value of this combined treatment of stage Ⅲ unresectable NSCLC were summarized.
2019 Vol. 28 (11): 872-875 [Abstract] ( 182 ) [HTML 1KB] [ PDF 0KB] ( 0 )
876 Research progress on PET-CT in radiotherapy planning for non-small cell lung cancer
Zhang Yingjie, Li Jianbin
18F-FDG PET-CT is recommended for the diagnosis and treatment of non-small cell lung cancer (NSCLC),and guiding the optimization of radiotherapy planning. The target area determined by biological information carried by functional images is defined as biological target volume (BTV). However,BTV significantly differs from the gross tumor volume (GTV) and internal target volume (ITV) defined by the International Commission on Radiation Units and Measurements (ICRU) report. It is still a challenging task to directly apply BTV to radiotherapy planning. The limitation of PET image,the accuracy of fusion with auxiliary anatomic images and the influence of respiratory movement cause the uncertainty of BTV definition in NSCLC patients. Referring to different anatomical images,multiple approaches can be employed to achieve BTV motion information compensation. Application of PET-CT in predicting the prognosis of NSCLC patients after radiotherapy and distinguishing the recurrence risk of biological sub-target contribute to achieving the dose planning for radiotherapy planning.
2019 Vol. 28 (11): 876-880 [Abstract] ( 239 ) [HTML 1KB] [ PDF 0KB] ( 0 )
中华放射肿瘤学杂志
 

News

 
·
·
More.....
 

Cooperation unit

 
  友 情 链 接  
 China Association for
 Science and Technology
 Chinese Medical Association
 Cancer Hospital of Chinese
 Academy of Medical
 Sciences Department of
 Radiation Oncology
 Chinese Anti-Cancer
 Association
 Chinese Journal of Lung
 Cancer
 Cqvp
 CNKI
 Wanfang Data
 More....  
 
  Copyright © 2010 Editorial By Chinese Journal of Radiation Oncology
Support by Beijing Magtech Co.ltd  support@magtech.com.cn